Brendan Smith

CRSP

Brendan Smith serves as Chief Financial Officer at CRISPR Therapeutics AG (CRSP). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$129.1K

Net Position

Net Seller

$129.1K

Companies Traded

CRSP

Active Period

Oct 2022 – Feb 2023

2 total trades

Most Recent

Sell CRSP

Feb 18, 2023 · $67.2K

Brendan Smith's Insider Trading at CRISPR Therapeutics AG (CRSP)

Buys

0 · $0.00

Sells

2 · $129.1K

Total Shares Bought

Total Shares Sold

2,503

CRSP Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 18, 2023	Sell	1,392	$48.26	$67.2K	0
Oct 14, 2022	Sell	1,111	$55.76	$61.9K	0

Related Insiders

KASINGER JAMES R.

General Counsel and Secretary

CRSPSell · Feb 18, 2026

Samarth Kulkarni

Chief Executive Officer

CRSPSell · Feb 18, 2026

Raju Prasad

Chief Financial Officer

CRSPSell · Jan 22, 2026

Douglas A Treco

Director

CRSPBuy · Aug 6, 2025

Simeon George

Director

CRSPBuy · Jul 16, 2025

Naimish Patel

Chief Medical Officer

CRSPSell · May 28, 2025

Explore More Insider Trading Data

CRSP Insider Trading Activity

View all insider trades at CRISPR Therapeutics AG

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity